Clinical Trial Update: Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes

View source ↗

Summary

Clinical trial evaluating biomarkers of intra-amniotic infection in women with preterm premature rupture of membranes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-amniotic Infection
• Preterm Birth

Snippet

Sponsor: ProteoGenix, Inc. | Conditions: Intra-amniotic Infection, Preterm Birth | Status: COMPLETED